Programmed drug delivery: nanosystems for tumor targeting
- 3 May 2007
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Biological Therapy
- Vol. 7 (5) , 587-593
- https://doi.org/10.1517/14712598.7.5.587
Abstract
Programmed nanoscaled systems are emerging that may be very useful for tumor-targeted drug delivery: novel nanoparticles are pre-programmed to alter their structure and properties during the drug delivery process to make them most effective for the different extra- and intracellular delivery steps. Programming is effected by the incorporation of molecular sensors that are able to respond to physical or biological stimuli, including changes in pH, redox potential or enzymes. Tumor-targeting principles include systemic passive targeting and active receptor targeting. Physical forces (e.g., electric or magnetic fields, ultrasound, hyperthermia or light) may contribute to focusing and triggered activation of nanosystems. Biological drugs delivered with programmed nanosystems also include plasmid DNA, small interfering RNA and related therapeutic nucleic acids formulated as ‘synthetic viruses’.Keywords
This publication has 78 references indexed in Scilit:
- Chemodosimetry of in vivo tumor liposomal drug concentration using MRIMagnetic Resonance in Medicine, 2006
- Pros and Cons of the Liposome Platform in Cancer Drug TargetingJournal of Liposome Research, 2006
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Polyacetal−Doxorubicin Conjugates Designed for pH-Dependent DegradationBioconjugate Chemistry, 2003
- The dawning era of polymer therapeuticsNature Reviews Drug Discovery, 2003
- A doxorubicin–CNGRC-peptide conjugate with prodrug propertiesBiochemical Pharmacology, 2002
- The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdvances in Enzyme Regulation, 2001
- Low-dose tumor necrosis factor-α augments antitumor activity of stealth liposomal doxorubicin (DOXIL®) in soft tissue sarcoma-bearing ratsInternational Journal of Cancer, 2000
- Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studiesBritish Journal of Cancer, 1996
- Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopyInternational Journal of Pharmaceutics, 1996